Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn
OBio Technology (Shanghai) announced the close of Series C of over CNY 300 minion, following the pre Series C of CNY 200 million in July 2020. As of today, the company has raised a total of CNY 600 million this year. Loyal Valley Capital led the investment, participated by Morning Side VC, Sherpa VC, ADFaith PE, GP Capital, BioTrack Capital and Shanghai Lingang Innovation Center.
OBio Technology, a contract development & manufacture organization (CDMO), has initiated a precision medicine smart production park as large as 80 thousand square meters. It aims to build a platform to attract genetic drugs worldwide, provide production clinical-level industry production service, and help domestic biotech fruits apply for licenses to enter overseas markets.